Neurent Medical
PrivateLast Round
Debt
Sep 9, 2026
Total Funding Raised
$159.07M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurent Medical is a medical device company that develops minimally invasive, non-surgical treatments for chronic inflammatory sinonasal diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurent Medical Comparables
Compare Neurent Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aerin Medical | 94% | |
| Stryker Corporation | 79% | |
| Olympus Corporation | 71% |
Neurent Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 9, 2026 | ||||
| Series C | Feb 11, 2026 | ||||
| Debt | Dec 18, 2024 | ||||
| Series B | Jan 20, 2021 | ||||
| Grant | Jul 9, 2020 | ||||
Series A | May 28, 2018 |
Key People
Founding team and executive leadership
Neurent Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Series C, Series B, Series A |
| EQT Life Sciences | Series C, Series B |
| Claret Capital Partners | Debt |
| Western Development Commission | Series A |
| Fountain Healthcare Partners | Series C, Series B, Series A |
| EIT Health | Grant |
| Sofinnova Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 17, 3x the trailing average.
- Feb 11, 2026
$74M round led by MVM Life Science Partners.
Neurent Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurent Medical's valuation, stock price, and market status.
Is Neurent Medical a public or private company?
Neurent Medical is a private company.
What is the current stock price of Neurent Medical?
Neurent Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Neurent Medical worth (valuation)?
Valuation information for Neurent Medical is not publicly available.
Can I buy Neurent Medical stock?
Neurent Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurent Medical's last funding round?
Neurent Medical's most recent funding round was Series C on February 11, 2026.
Who are the main investors in Neurent Medical?
Key investors in Neurent Medical include EQT Life Sciences, Fountain Healthcare Partners, MVM Life Science Partners LLP.
Will Neurent Medical IPO soon?
No public IPO plans have been announced for Neurent Medical.
How can I track Neurent Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurent Medical's secondary market activity and sign up for updates.